{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T22:35:25Z","timestamp":1784673325325,"version":"3.55.0"},"reference-count":23,"publisher":"American Diabetes Association","issue":"9","license":[{"start":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T00:00:00Z","timestamp":1630108800000},"content-version":"vor","delay-in-days":4436,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,9,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>The aim of this analysis was to assess the prospective association of serum testosterone and dehydroepiandrosterone sulfate (DHEAS) levels with incident metabolic syndrome (MetS) in men.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>Data were obtained from the Study of Health in Pomerania (SHIP), a population-based prospective cohort of adults aged 20\u201379 years. Analyses were conducted in 1,004 men without baseline MetS defined by National Cholesterol Education Program Adult Treatment Panel III guidelines. Testosterone and DHEAS were categorized by age-specific quartiles and Poisson regression models with relative risks (RRs) and 95% CIs were estimated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>After a median follow-up time of 5.0 years, 480 men (47.8%) developed MetS. Testosterone levels decreased with increasing number of MetS components. Testosterone in the lowest quartile predicted MetS (RR 1.38 [95% CI 1.13\u20131.69]), particularly among men aged 20\u201339 years (2.06 [1.29\u20133.29]), even after adjustment for age, smoking, alcohol consumption, physical activity, waist circumference, self-related health, and time of blood sampling. DHEAS levels were not related to incident MetS (0.99 [0.83\u20131.19]).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Low testosterone but not DHEAS predicts development of MetS in a population-based cohort of 1,004 men aged 20\u201379 years. Especially in young men aged 20\u201339 years, results suggest low testosterone as a strong predictor for incident MetS. Assessment of testosterone in young and middle-age men may allow early interventions in the general population.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/db09-0031","type":"journal-article","created":{"date-parts":[[2009,7,7]],"date-time":"2009-07-07T01:28:50Z","timestamp":1246930130000},"page":"2027-2031","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":130,"title":["Prediction of Metabolic Syndrome by Low Serum Testosterone Levels in Men"],"prefix":"10.2337","volume":"58","author":[{"given":"Robin","family":"Haring","sequence":"first","affiliation":[{"name":"Institute of Clinical Chemistry and Laboratory Medicine, Ernst Moritz Arndt University Greifswald, Greifswald, Germany;"},{"name":"Institute for Community Medicine, Ernst Moritz Arndt University Greifswald, Greifswald, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"V\u00f6lzke","sequence":"additional","affiliation":[{"name":"Institute for Community Medicine, Ernst Moritz Arndt University Greifswald, Greifswald, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan B.","family":"Felix","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ernst Moritz Arndt University Greifswald, Greifswald, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Schipf","sequence":"additional","affiliation":[{"name":"Institute of Clinical Chemistry and Laboratory Medicine, Ernst Moritz Arndt University Greifswald, Greifswald, Germany;"},{"name":"Institute for Community Medicine, Ernst Moritz Arndt University Greifswald, Greifswald, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"D\u00f6rr","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ernst Moritz Arndt University Greifswald, Greifswald, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Rosskopf","sequence":"additional","affiliation":[{"name":"Institute of Pharmacology, Ernst Moritz Arndt University Greifswald, Greifswald, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Nauck","sequence":"additional","affiliation":[{"name":"Institute of Clinical Chemistry and Laboratory Medicine, Ernst Moritz Arndt University Greifswald, Greifswald, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christof","family":"Sch\u00f6fl","sequence":"additional","affiliation":[{"name":"Division of Neuroendocrinology, Department of Neurosurgery, Friedrich-Alexander-University Erlangen, Nuremberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Wallaschofski","sequence":"additional","affiliation":[{"name":"Institute of Clinical Chemistry and Laboratory Medicine, Ernst Moritz Arndt University Greifswald, Greifswald, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2009,7,6]]},"reference":[{"key":"2022031215424928000_B1","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1210\/er.2004-0013","article-title":"The decline of androgen levels in elderly men and its clinical and therapeutic implications","volume":"26","author":"Kaufman","year":"2005","journal-title":"Endocr Rev"},{"key":"2022031215424928000_B2","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1530\/eje.0.1490601","article-title":"Sex hormones, inflammation and the metabolic syndrome: a population-based study","volume":"149","author":"Laaksonen","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"2022031215424928000_B3","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1210\/jc.2004-1158","article-title":"Endogenous sex hormones and metabolic syndrome in aging men","volume":"90","author":"Muller","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031215424928000_B4","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.2337\/diacare.27.5.1036","article-title":"Testosterone and sex hormone\u2013binding globulin predict the metabolic syndrome and diabetes in middle-aged men","volume":"27","author":"Laaksonen","year":"2004","journal-title":"Diabetes Care"},{"key":"2022031215424928000_B5","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1210\/jc.2008-0054","article-title":"Inverse association of testosterone and the metabolic syndrome in men is consistent across race and ethnic groups","volume":"93","author":"Kupelian","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031215424928000_B6","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"2022031215424928000_B7","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0026-0495(94)90202-X","article-title":"Decreased testosterone and dehydroepiandrosterone sulfate concentrations are associated with increased insulin and glucose concentrations in nondiabetic men","volume":"43","author":"Haffner","year":"1994","journal-title":"Metabolism"},{"key":"2022031215424928000_B8","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jclinepi.2008.06.010","article-title":"Extended recruitment efforts minimize attrition but not necessarily bias","volume":"62","author":"Haring","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"2022031215424928000_B9","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/BF01324255","article-title":"Study of Health In Pomerania (SHIP): a health examination survey in an east German region: objectives and design","volume":"46","author":"John","year":"2001","journal-title":"Soz Praventivmed"},{"key":"2022031215424928000_B10","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1097\/01.ALC.0000128383.34605.16","article-title":"Laboratory markers carbohydrate-deficient transferrin, gamma-glutamyltransferase, and mean corpuscular volume are not useful as screening tools for high-risk drinking in the general population: results from the Study of Health in Pomerania (SHIP)","volume":"28","author":"Alte","year":"2004","journal-title":"Alcohol Clin Exp Res"},{"key":"2022031215424928000_B11","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute scientific statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"2022031215424928000_B12","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1046\/j.1463-1326.2003.00250.x","article-title":"Socio-demographic and psychosocial factors are associated with features of the metabolic syndrome: the Women's Health in the Lund Area (WHILA) study","volume":"5","author":"Lidfeldt","year":"2003","journal-title":"Diabetes Obes Metab"},{"key":"2022031215424928000_B13","doi-asserted-by":"crossref","first-page":"610","DOI":"10.2164\/jandrol.108.005561","article-title":"Reference ranges for serum dehydroepiandrosterone sulfate and testosterone in adult men","volume":"29","author":"Friedrich","year":"2008","journal-title":"J Androl"},{"key":"2022031215424928000_B14","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1093\/clinchem\/41.12.1761","article-title":"Quantitative determination of high-, low-, and very-low-density lipoproteins and lipoprotein(a) by agarose gel electrophoresis and enzymatic cholesterol staining","volume":"41","author":"Nauck","year":"1995","journal-title":"Clin Chem"},{"key":"2022031215424928000_B15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1373\/clinchem.2007.099705","article-title":"Uric acid, type 2 diabetes, and cardiovascular diseases: fueling the common soil hypothesis?","volume":"54","author":"Koenig","year":"2008","journal-title":"Clin Chem"},{"key":"2022031215424928000_B16","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1462-8902.2004.00335.x","article-title":"Changes in sex hormone-binding globulin and testosterone during weight loss and weight maintenance in abdominally obese men with the metabolic syndrome","volume":"6","author":"Niskanen","year":"2004","journal-title":"Diabetes Obes Metab"},{"key":"2022031215424928000_B17","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1210\/jc.2004-1933","article-title":"Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T","volume":"90","author":"Page","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031215424928000_B18","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/01485010701730880","article-title":"An exploratory study of the effects of 12 month administration of the novel long-acting testosterone undecanoate on measures of sexual function and the metabolic syndrome","volume":"53","author":"Saad","year":"2007","journal-title":"Arch Androl"},{"key":"2022031215424928000_B19","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2337\/dc06-0145","article-title":"The metabolic syndrome is frequent in Klinefelter's syndrome and is associated with abdominal obesity and hypogonadism","volume":"29","author":"Bojesen","year":"2006","journal-title":"Diabetes Care"},{"key":"2022031215424928000_B20","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1200\/JCO.2006.05.9741","article-title":"Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy","volume":"24","author":"Braga-Basaria","year":"2006","journal-title":"J Clin Oncol"},{"key":"2022031215424928000_B21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/aje\/153.1.79","article-title":"Low dehydroepiandrosterone and ischemic heart disease in middle-aged men: prospective results from the Massachusetts Male Aging Study","volume":"153","author":"Feldman","year":"2001","journal-title":"Am J Epidemiol"},{"key":"2022031215424928000_B22","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2143\/AC.58.5.2005304","article-title":"Are low dehydroepiandrosterone sulphate levels predictive for cardiovascular diseases?: a review of prospective and retrospective studies","volume":"58","author":"Thijs","year":"2003","journal-title":"Acta Cardiol"},{"key":"2022031215424928000_B23","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/1471-2458-7-220","article-title":"Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study","volume":"7","author":"Hildrum","year":"2007","journal-title":"BMC Public Health"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/58\/9\/2027\/392925\/zdb00909002027.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/58\/9\/2027\/392925\/zdb00909002027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:18:28Z","timestamp":1667405908000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/58\/9\/2027\/23947\/Prediction-of-Metabolic-Syndrome-by-Low-Serum"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,6]]},"references-count":23,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2009,7,6]]},"published-print":{"date-parts":[[2009,9,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db09-0031","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,6]]}}}